Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-04-07

Clinical Trial Update: Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating long-term efficacy and safety of asenapine with haloperidol as a positive control in schizophrenia; study completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asenapine (asenapine)
  • HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

Sponsor: Organon and Co | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2010-04-07